Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Interim Review

4 Oct 2010 17:04

RNS Number : 8347T
Hikma Pharmaceuticals Plc
04 October 2010
 



 

Block Listing Six Monthly Return

 

Information provided on this form must be typed or printed electronically and provided to an RIS.

 

Date: 4 October 2010

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

&

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

Period of return

From:

1 April 2010

To:

4 October 2010

Balance of unallotted securities under scheme(s) from previous return:

SOP: 1,486,200 ordinary shares of 10 pence each

LTIP: 700,000 ordinary shares of 10 pence each

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 841,482 ordinary shares of 10 pence each

LTIP: 488,000 ordinary shares of 10 pence each

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 644,718 ordinary shares of 10 pence each

LTIP: 212,000 ordinary shares of 10 pence each

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

 

 

Long Term Incentive Plan ("LTIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

17/03/2010

700,000

0

700,000

06/04/2010

0

55,000

645,000

16/04/2010

0

25,000

620,000

19/04/2010

0

25,000

595,000

22/04/2010

0

30,000

565,000

23/04/2010

0

195,000

370,000

23/04/2010

0

86,000

284,000

27/04/2010

0

22,000

262,000

10/05/2010

0

11,000

251,000

14/05/2010

0

6,000

245,000

21/05/2010

0

10,000

235,000

07/06/2010

0

8,000

227,000

18/06/2010

0

5,000

222,000

10/09/2010

0

10,000

212,000

 

 

Stock Option Plan ("SOP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

26/03/2010

0

20,000

1,486,200

The LTIP block listed shares have been separated from the SOP

31/03/2010

0

97,000

1,389,200

06/04/2010

0

167,100

1,222,100

08/04/2010

0

190,000

1,032,100

13/04/2010

0

39,400

992,700

16/04/2010

0

17,600

975,100

22/04/2010

0

13,582

961,518

23/04/2010

0

30,000

931,518

26/04/2010

0

75,100

856,418

04/05/2010

0

24,300

832,118

10/05/2010

0

15,200

816,918

14/05/2010

0

22,400

794,518

21/05/2010

0

23,000

771,518

25/05/2010

0

3,400

768,118

28/05/2010

0

7,000

761,118

07/06/2010

0

23,700

737,418

11/06/2010

0

3,400

734,018

18/06/2010

0

28,800

705,218

25/06/2010

0

14,600

690,618

30/06/2010

0

25,000

665,618

03/09/2010

0

17,500

648,118

24/09/2010

0

3,400

644,718

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGMMGGVDFGGZM
Date   Source Headline
5th Jun 20242:53 pmRNSDirector/PDMR Shareholding
9th May 20249:49 amRNSDirector/PDMR Shareholding
25th Apr 20242:28 pmRNSResult of AGM
25th Apr 20247:00 amRNSTrading Statement
17th Apr 202410:42 amRNSDirector/PDMR Shareholding
15th Apr 20244:43 pmRNSHikma appoints new President of Generics business
11th Apr 202410:58 amRNSDirector/PDMR Shareholding
2nd Apr 20249:50 amRNSBlock listing Interim Review
22nd Mar 20249:21 amRNSAnnual Financial Report and Notice of AGM
13th Mar 20249:42 amRNSDirector/PDMR Shareholding
7th Mar 20241:52 pmRNSDirector/PDMR Shareholding
1st Mar 202410:17 amRNSTotal Voting Rights
22nd Feb 20247:00 amRNSFinal Results
5th Feb 20248:46 amRNSNotice of Results
1st Feb 20246:22 pmRNSAgreement in Principle for US Opioid Settlement
1st Feb 202412:08 pmRNSTotal Voting Rights
2nd Jan 20243:24 pmRNSTotal Voting Rights
29th Dec 20237:00 amRNSCompany Secretary Change
1st Dec 20237:00 amRNSTotal Voting Rights
2nd Nov 20237:00 amRNSTrading Statement
2nd Oct 202310:13 amRNSBlock listing Interim Review
2nd Oct 202310:04 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20234:14 pmRNSDirector/PDMR Shareholding
11th Aug 20232:00 pmRNSDirector/PDMR Shareholding
10th Aug 20234:53 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report
17th Jul 20239:11 amRNSNotice of Results
14th Jun 202310:03 amRNSHolding(s) in Company
8th Jun 202310:25 amRNSDirector/PDMR Shareholding
31st May 20233:20 pmRNSDirector/PDMR Shareholding
23rd May 20234:14 pmRNSHolding(s) in Company
17th May 20239:56 amRNSDirector/PDMR Shareholding
2nd May 202310:53 amRNSTotal Voting Rights
28th Apr 20233:25 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Statement
24th Apr 20234:15 pmRNSDirector/PDMR Shareholding
12th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20239:27 amRNSBlock listing Interim Review
3rd Apr 20239:19 amRNSTotal Voting Rights
16th Mar 202310:17 amRNSAnnual Financial Report and Notice of AGM
2nd Mar 20239:30 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSFinal Results
17th Feb 202310:20 amRNSHolding(s) in Company
7th Feb 20239:36 amRNSNotice of Results
1st Feb 202310:18 amRNSTotal Voting Rights
18th Jan 202310:16 amRNSDirector/PDMR Shareholding
18th Jan 20239:39 amRNSHolding(s) in Company
17th Jan 202311:58 amRNSHolding(s) in Company
10th Jan 20233:42 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.